Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.50 |
| ▸ | ARG1 | P05089 | 1/20 | 0.50 |
| ▸ | ARG2 | P78540 | 1/20 | 0.50 |
| ▸ | NOS2 | P35228 | 3/20 | 0.48 |
| ▸ | NOS1 | P29475 | 2/20 | 0.48 |
| ▸ | NOS3 | P29474 | 1/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 4/20 | 0.48 |
| ▸ | GRIK2 | Q13002 | 4/20 | 0.48 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.48 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.48 |
| ▸ | GSR | P00390 | 2/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.46 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | GRM8 | O00222 | 1/20 | 0.46 |
| ▸ | GRM6 | O15303 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cystine SCHEMBL30540421 | 1.00 | PTGS1 (0.50) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL5018669 | 1.00 | PTGS1 (0.50) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL8332356 | 1.00 | PTGS1 (0.50) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL10224 | 1.00 | PTGS1 (0.50) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL8332353 | 1.00 | PTGS1 (0.50) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL21114356 | 1.00 | PTGS1 (0.50) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL222059 | 1.00 | PTGS1 (0.50) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL10225 | 1.00 | PTGS1 (0.50) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL8332360 | 1.00 | PTGS1 (0.50) | PTGS1SLC7A11ARG1ARG2NOS2 | |
| Cystine SCHEMBL10335533 | 1.00 | PTGS1 (0.50) | PTGS1SLC7A11ARG1ARG2NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630411-A1 | FORMULATION FOR AROMATIZING A FOOD PRODUCT | Döhler GmbH (DE) | 2025-10-15 | — | — | EP | claimed |
| WO-2024120760-A1 | FORMULATION FOR AROMATIZING A FOOD PRODUCT | DÖHLER GmbH (DE) | 2024-06-13 | — | — | WO | claimed |
| EP-2621462-B1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | PROCTER & GAMBLE (US) | 2020-02-12 | — | — | EP | claimed |
| EP-2621462-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | The Procter and Gamble Company (US) | 2013-08-07 | — | — | EP | claimed |
| WO-2012044728-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | THE PROCTER & GAMBLE COMPANY (US) | 2012-04-05 | — | — | WO | claimed |
| US-20120082628-A1 | Oral Care Compositions With Improved Flavor | THE PROCTER & GAMBLE COMPANY | 2012-04-05 | — | — | US | claimed |
| EP-4630411-A1 | FORMULATION FOR AROMATIZING A FOOD PRODUCT | Döhler GmbH (DE) | 2025-10-15 | — | — | EP | disclosed |
| EP-3383502-B1 | ORAL CARE PRODUCT AND METHODS OF USE AND MANUFACTURE THEREOF | COLGATE PALMOLIVE CO (US) | 2025-03-05 | — | — | EP | disclosed |
| WO-2024120760-A1 | FORMULATION FOR AROMATIZING A FOOD PRODUCT | DÖHLER GmbH (DE) | 2024-06-13 | — | — | WO | disclosed |
| US-20230310461-A1 | Compositions and Methods for Treatment of Prediabetes | CROSS III WILLIAM H (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230310461-A1 | Compositions and Methods for Treatment of Prediabetes | CROSS III WILLIAM H (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230201246-A1 | METAL COMPOSITIONS AND METHODS OF USE THEREOF | UNIVERSITY OF MASSACHUSETTS | 2023-06-29 | — | — | US | disclosed |
| US-20230201246-A1 | METAL COMPOSITIONS AND METHODS OF USE THEREOF | UNIVERSITY OF MASSACHUSETTS | 2023-06-29 | — | — | US | disclosed |
| WO-2007098466-A2 | SEGMENTED DEGRADABLE POLYMERS AND CONJUGATES MADE THEREFROM | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2007-08-30 | — | — | WO | disclosed |
| EP-0245362-A4 | SYNTHETIC PEPTIDES AND USE FOR DIAGNOSIS AND VACCINATION FOR AIDS AND ARC. | SOUTHWEST FOUND BIOMED RES (US) | 1990-04-10 | — | — | EP | disclosed |
| EP-0276279-A4 | COMPOSITION OF MATTER AND METHOD OF IMMUNIZING AGAINST VIRAL CAUSATIVE AGENTS OF AIDS AND ARC. | SOUTHWEST FOUND BIOMED RES (US) | 1990-01-08 | — | — | EP | disclosed |
| EP-0276279-A1 | COMPOSITION OF MATTER AND METHOD OF IMMUNIZING AGAINST VIRAL CAUSATIVE AGENTS OF AIDS AND ARC | SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH (US) | 1988-08-03 | — | — | EP | disclosed |
| WO-1988000471-A1 | COMPOSITION OF MATTER AND METHOD OF IMMUNIZING AGAINST VIRAL CAUSATIVE AGENTS OF AIDS AND ARC | SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH (US) | 1988-01-28 | — | — | WO | disclosed |
| EP-0245362-A1 | SYNTHETIC PEPTIDES AND USE FOR DIAGNOSIS AND VACCINATION FOR AIDS AND ARC. | SOUTHWEST FOUND BIOMED RES (US) | 1987-11-19 | — | — | EP | disclosed |
| WO-1987002775-A1 | SYNTHETIC PEPTIDES AND USE FOR DIAGNOSIS AND VACCINATION FOR AIDS AND ARC | SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH (US) | 1987-05-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230201246-A1 | METAL COMPOSITIONS AND METHODS OF USE THEREOF | SOD1, SOD3, SLC30A5 | PTGS1 2350/4885SLC7A11 1265/4885ARG1 177/4885 |
| US-20230310461-A1 | Compositions and Methods for Treatment of Prediabetes | GPX1, GPX4, NFE2L2 | PTGS1 820/4885SLC7A11 1135/4885ARG1 2269/4885 |
| US-20120082628-A1 | Oral Care Compositions With Improved Flavor | TRPA1, TAS2R40, TAS2R30 | PTGS1 2908/4885SLC7A11 3887/4885ARG1 2733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.